S.I.M.S

S.I.M.S. (Società Italiana Medicinali Scandicci) is a specialized Italian pharmaceutical company dedicated to the development and manufacture of Active Pharmaceutical Ingredients (APIs). Established in 1937, the company has built a global reputation for its expertise in the chemical synthesis of complex small molecules, particularly controlled substances such as narcotics and corticosteroids. Operating from a GMP-certified facility in Reggello, Italy, SIMS provides both off-the-shelf API products and custom contract development and manufacturing (CDMO) services. Their portfolio includes critical treatments for pain management and opioid addiction, such as Methadone and Buprenorphine. The company maintains rigorous compliance with international regulatory standards, including frequent inspections by the FDA and AIFA.